Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 18.46 Thousand USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 397.5 Thousand USD | 0.0% |
| 2019 | 397.5 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 397.5 Thousand USD | 2.45% |
| 2015 | 388 Thousand USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 898.33 Thousand USD | 357.58% |
| 2012 | 196.32 Thousand USD | -6.32% |
| 2011 | 209.57 Thousand USD | -13.12% |
| 2010 | 241.23 Thousand USD | -66.92% |
| 2009 | 729.3 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 14.71 Thousand USD | 0.0% |
| 2024 Q2 | 10.81 Thousand USD | 0.0% |
| 2023 FY | 18.46 Thousand USD | 0.0% |
| 2023 Q1 | 29.16 Thousand USD | 0.0% |
| 2023 Q4 | 18.46 Thousand USD | -16.46% |
| 2023 Q3 | 22.1 Thousand USD | -82.97% |
| 2023 Q2 | 129.83 Thousand USD | 345.26% |
| 2022 FY | - USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | 397.5 Thousand USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q4 | 397.5 Thousand USD | 0.0% |
| 2021 Q1 | 397.5 Thousand USD | 0.0% |
| 2020 Q3 | 397.5 Thousand USD | 0.0% |
| 2020 FY | 397.5 Thousand USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q2 | 397.5 Thousand USD | 0.0% |
| 2020 Q4 | 397.5 Thousand USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | 397.5 Thousand USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | 397.5 Thousand USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q1 | 397.5 Thousand USD | 0.0% |
| 2017 FY | - USD | -100.0% |
| 2016 Q4 | 397.5 Thousand USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q3 | 397.5 Thousand USD | 0.0% |
| 2016 FY | 397.5 Thousand USD | 2.45% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | 388 Thousand USD | 0.0% |
| 2015 Q1 | 2.5 Million USD | 0.0% |
| 2015 FY | 388 Thousand USD | 0.0% |
| 2015 Q2 | - USD | -100.0% |
| 2014 Q3 | 2.5 Million USD | 0.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q4 | - USD | -100.0% |
| 2014 Q2 | 2.5 Million USD | 171.44% |
| 2014 Q1 | 921.01 Thousand USD | 2.52% |
| 2013 Q1 | 2.79 Million USD | 1326.04% |
| 2013 Q2 | 228.55 Thousand USD | -91.84% |
| 2013 Q3 | 258.38 Thousand USD | 13.05% |
| 2013 Q4 | 898.33 Thousand USD | 247.67% |
| 2013 FY | 898.33 Thousand USD | 357.58% |
| 2012 Q2 | 249.95 Thousand USD | 12.97% |
| 2012 Q3 | 276.97 Thousand USD | 10.81% |
| 2012 Q4 | 196.32 Thousand USD | -29.12% |
| 2012 FY | 196.32 Thousand USD | -6.32% |
| 2012 Q1 | 221.25 Thousand USD | 5.57% |
| 2011 Q1 | 251.19 Thousand USD | 4.13% |
| 2011 Q2 | 263.34 Thousand USD | 4.83% |
| 2011 Q4 | 209.57 Thousand USD | -19.69% |
| 2011 FY | 209.57 Thousand USD | -13.12% |
| 2011 Q3 | 260.95 Thousand USD | -0.91% |
| 2010 Q2 | 538.89 Thousand USD | 29.12% |
| 2010 FY | 241.23 Thousand USD | -66.92% |
| 2010 Q4 | 241.23 Thousand USD | -60.02% |
| 2010 Q3 | 603.34 Thousand USD | 11.96% |
| 2010 Q1 | 417.37 Thousand USD | -42.77% |
| 2009 Q3 | 467.5 Thousand USD | -81.3% |
| 2009 Q4 | 729.3 Thousand USD | 56.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | 2.5 Million USD | 0.0% |
| 2009 FY | 729.3 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 99.997% |
| Ansell Limited | 706.6 Million USD | 99.997% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 99.918% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | 97.045% |
| ConvaTec Group Plc | 1.22 Billion USD | 99.998% |
| ConvaTec Group Plc | 1.22 Billion USD | 99.998% |
| Encision Inc. | 67.33 Thousand USD | 72.573% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | 95.176% |
| LifePoint, Inc. | 151.73 Thousand USD | 87.829% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 99.624% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | 96.997% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | 89.738% |
| SmileDirectClub, Inc. | 849.37 Million USD | 99.998% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 99.991% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | 61.913% |
| Vasamed, Inc. | 18.95 Thousand USD | 2.544% |
| Yubo International Biotech Limited | 390.44 Thousand USD | 95.27% |